Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
- PMID: 20045095
- DOI: 10.1016/j.vaccine.2009.12.042
Determinants for HPV vaccine uptake in the Netherlands: A multilevel study
Abstract
In March 2009, a HPV catch-up vaccination campaign was implemented in the Netherlands for girls born between 1993 and 1996. We performed a multilevel study to investigate determinants for HPV vaccination uptake. National coverage for the first dose was 49.9%, with regional uptakes ranging from 31% to 61%. Data was gathered from individual to regional level. Our results suggest that organizing information meetings at schools and communicating with gynaecologists might be beneficial. Lower uptake among various ethnic groups and in areas with higher proportion of voters for Religious Political Parties indicate that communication on HPV vaccine should be adapted to religious and ethnic communities. Furthermore, lower uptake in areas with lower socioeconomic status needs attention since participation to cervical screening is also lower in these areas.
Copyright 2009 Elsevier Ltd. All rights reserved.
Similar articles
-
Human papillomavirus vaccine initiation among adolescent girls in high-risk communities.Vaccine. 2011 Mar 9;29(12):2235-41. doi: 10.1016/j.vaccine.2011.01.052. Epub 2011 Feb 1. Vaccine. 2011. PMID: 21288799
-
Challenges, lessons learned and results following the implementation of a human papilloma virus school vaccination program in South Australia.Aust N Z J Public Health. 2009 Aug;33(4):365-70. doi: 10.1111/j.1753-6405.2009.00409.x. Aust N Z J Public Health. 2009. PMID: 19689598
-
Behavioral interventions to increase HPV vaccination acceptability among mothers of young girls.Health Psychol. 2010 Jan;29(1):29-39. doi: 10.1037/a0016942. Health Psychol. 2010. PMID: 20063933
-
[Vaccines against human papillomavirus (HPV); between registration and implementation].Ned Tijdschr Geneeskd. 2008 Apr 26;152(17):987-92. Ned Tijdschr Geneeskd. 2008. PMID: 18549172 Review. Dutch.
-
Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean.Vaccine. 2008 Aug 19;26 Suppl 11:L73-9. doi: 10.1016/j.vaccine.2008.05.027. Vaccine. 2008. PMID: 18945404 Review.
Cited by
-
Continuing reductions in HPV 16/18 in a population with high coverage of bivalent HPV vaccination in England: an ongoing cross-sectional study.BMJ Open. 2016 Feb 11;6(2):e009915. doi: 10.1136/bmjopen-2015-009915. BMJ Open. 2016. PMID: 26868944 Free PMC article.
-
Area and individual level analyses of demographic and socio-economic disparities in COVID-19 vaccination uptake in Belgium.Vaccine X. 2024 May 3;18:100496. doi: 10.1016/j.jvacx.2024.100496. eCollection 2024 Jun. Vaccine X. 2024. PMID: 38779406 Free PMC article.
-
Application of real-time global media monitoring and 'derived questions' for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines.BMC Med. 2017 May 2;15(1):91. doi: 10.1186/s12916-017-0850-4. BMC Med. 2017. PMID: 28464900 Free PMC article.
-
Turkish and Moroccan Dutch women's views of using a self-sampling kit for human papillomavirus testing as a tool for cervical cancer screening: What are the barriers and the motivators?Womens Health (Lond). 2021 Jan-Dec;17:17455065211065873. doi: 10.1177/17455065211065873. Womens Health (Lond). 2021. PMID: 34903110 Free PMC article.
-
Sociodemographic predictors are associated with compliance to a vaccination-reminder in 9692 girls age 14, Denmark 2014-2015.Prev Med Rep. 2018 Feb 23;10:93-99. doi: 10.1016/j.pmedr.2018.02.005. eCollection 2018 Jun. Prev Med Rep. 2018. PMID: 29868358 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources